.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Analyze global market entry opportunities
  • Drug patents and clinical trials in dozens of countries

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

DrugPatentWatch Database Preview

FENOFIBRATE Drug Profile

« Back to Dashboard

Which patents cover Fenofibrate, and what substitute generic drugs are available?

Fenofibrate is a drug marketed by Cipla Ltd, Impax Labs, Valeant Pharms North, Aurobindo Pharma Ltd, Lupin Ltd, Mylan, Rhodes Pharms, Sun Pharm Inds Ltd, Mylan Pharms Inc, Hetero Labs Ltd Iii, Apotex Inc, and Dr Reddys Labs Sa. and is included in nineteen NDAs.

The generic ingredient in FENOFIBRATE is fenofibrate. There are forty-one drug master file entries for this compound. Forty-nine suppliers are listed for this compound. There is one tentative approval for this compound. Additional details are available on the fenofibrate profile page.

Summary for Tradename: FENOFIBRATE

Patents:0
Applicants:12
NDAs:19
Suppliers / Packagers: see list32
Bulk Api Vendors: see list80
Clinical Trials: see list35
Patent Applications: see list5,163
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:FENOFIBRATE at DailyMed

Pharmacology for Tradename: FENOFIBRATE

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Pharms Inc
FENOFIBRATE (MICRONIZED)
fenofibrate
CAPSULE;ORAL202676-003Oct 23, 2012RXNoNo► Subscribe► Subscribe
Rhodes Pharms
FENOFIBRATE (MICRONIZED)
fenofibrate
CAPSULE;ORAL075753-002Apr 9, 2002RXNoNo► Subscribe► Subscribe
Hetero Labs Ltd Iii
FENOFIBRATE
fenofibrate
TABLET;ORAL204598-002Jul 12, 2016RXNoNo► Subscribe► Subscribe
Rhodes Pharms
FENOFIBRATE (MICRONIZED)
fenofibrate
CAPSULE;ORAL075753-003Apr 9, 2002RXNoYes► Subscribe► Subscribe
Apotex Inc
FENOFIBRATE (MICRONIZED)
fenofibrate
CAPSULE;ORAL202252-001Jul 26, 2013RXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc